Cingulate Inc.
CINGW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001862150
No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.88K in total; no superinvestor holds it.
Other share classesCING
Q4 2023 vs. Q3 2023
How the institutions holding Cingulate Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 8 | 8 | 0 |
| Shares | 1.55M | 1.54M | −3.83K (−0.2%) |
| Value | $255.4K | $34.6K | −$220.7K (−86.4%) |
New holders (1)
Institutions that held Cingulate Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 200 | $6 | 0.00% |
Sold out (1)
Institutions that held Cingulate Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Lynwood Capital Management Inc. | 50,000 | $8.25K |